Cargando…

597. Pharmacist-Led Interventions for Inpatient HIV-Related Medication Errors

BACKGROUND: Inpatient HIV-related medication errors occur in up to 86% of patients. The purpose of this study was to evaluate the number of antiretroviral therapy (ART)- and opportunistic infection (OI)-related medication errors following the implementation of pharmacist-directed interventions. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Wingler, Mary Joyce B, Stover, Kayla R, Barber, Katie E, Wagner, Jamie L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254135/
http://dx.doi.org/10.1093/ofid/ofy210.604
_version_ 1783373654578429952
author Wingler, Mary Joyce B
Stover, Kayla R
Barber, Katie E
Wagner, Jamie L
author_facet Wingler, Mary Joyce B
Stover, Kayla R
Barber, Katie E
Wagner, Jamie L
author_sort Wingler, Mary Joyce B
collection PubMed
description BACKGROUND: Inpatient HIV-related medication errors occur in up to 86% of patients. The purpose of this study was to evaluate the number of antiretroviral therapy (ART)- and opportunistic infection (OI)-related medication errors following the implementation of pharmacist-directed interventions. METHODS: This quasi-experiment assessed adult patients with HIV who received ART, OI prophylaxis, or both from December 1, 2014 to February 28, 2017 (pre-intervention) or December 1, 2017 to February 28, 2018 (post-intervention). Pre-intervention patients were assessed retrospectively, verbal and written education were provided, then prospective audit and feedback was conducted for post-intervention patients. The primary outcome was rate of ART-related medication errors in the pre- vs. post-intervention groups. Secondary outcomes included time to resolution of ART- and OI-related medication errors, OI-related medication errors, types of errors, rate of acceptance of recommendations, in-hospital mortality, length of stay, and 30-day readmission. RESULTS: Sixty-seven patients were included in each group (pre- and post-intervention). ART errors occurred in 44.8% and 32.8% (P = 0.156), respectively. OI prophylaxis errors occurred in 11.9% vs. 9% (P = 0.572), respectively. No difference was found in types of errors between groups, except medication omission decreased significantly in the post-intervention group (31.3% vs. 11.9%; P = 0.006). The number of pharmacist-based interventions increased in the post-intervention group (6.3% vs. 52.9%; P = 0.001). No statistical difference was found in average time to error resolution (72 vs. 48 hours; P = 0.123), but errors resolved during admission significantly increased (50% vs. 86.8%; P < 0.001). No difference was found in rate of intervention acceptance, which was high in both groups. CONCLUSION: In this quasi-experiment, ART and OI prophylaxis medication errors were numerically reduced in the pharmacist-led intervention period, and medication errors were resolved a day faster in the post-intervention period. Future interventions targeting prescribing errors upon admission include follow-up education and evaluation of medication reconciliation practices in HIV-infected patients. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6254135
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62541352018-11-28 597. Pharmacist-Led Interventions for Inpatient HIV-Related Medication Errors Wingler, Mary Joyce B Stover, Kayla R Barber, Katie E Wagner, Jamie L Open Forum Infect Dis Abstracts BACKGROUND: Inpatient HIV-related medication errors occur in up to 86% of patients. The purpose of this study was to evaluate the number of antiretroviral therapy (ART)- and opportunistic infection (OI)-related medication errors following the implementation of pharmacist-directed interventions. METHODS: This quasi-experiment assessed adult patients with HIV who received ART, OI prophylaxis, or both from December 1, 2014 to February 28, 2017 (pre-intervention) or December 1, 2017 to February 28, 2018 (post-intervention). Pre-intervention patients were assessed retrospectively, verbal and written education were provided, then prospective audit and feedback was conducted for post-intervention patients. The primary outcome was rate of ART-related medication errors in the pre- vs. post-intervention groups. Secondary outcomes included time to resolution of ART- and OI-related medication errors, OI-related medication errors, types of errors, rate of acceptance of recommendations, in-hospital mortality, length of stay, and 30-day readmission. RESULTS: Sixty-seven patients were included in each group (pre- and post-intervention). ART errors occurred in 44.8% and 32.8% (P = 0.156), respectively. OI prophylaxis errors occurred in 11.9% vs. 9% (P = 0.572), respectively. No difference was found in types of errors between groups, except medication omission decreased significantly in the post-intervention group (31.3% vs. 11.9%; P = 0.006). The number of pharmacist-based interventions increased in the post-intervention group (6.3% vs. 52.9%; P = 0.001). No statistical difference was found in average time to error resolution (72 vs. 48 hours; P = 0.123), but errors resolved during admission significantly increased (50% vs. 86.8%; P < 0.001). No difference was found in rate of intervention acceptance, which was high in both groups. CONCLUSION: In this quasi-experiment, ART and OI prophylaxis medication errors were numerically reduced in the pharmacist-led intervention period, and medication errors were resolved a day faster in the post-intervention period. Future interventions targeting prescribing errors upon admission include follow-up education and evaluation of medication reconciliation practices in HIV-infected patients. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6254135/ http://dx.doi.org/10.1093/ofid/ofy210.604 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Wingler, Mary Joyce B
Stover, Kayla R
Barber, Katie E
Wagner, Jamie L
597. Pharmacist-Led Interventions for Inpatient HIV-Related Medication Errors
title 597. Pharmacist-Led Interventions for Inpatient HIV-Related Medication Errors
title_full 597. Pharmacist-Led Interventions for Inpatient HIV-Related Medication Errors
title_fullStr 597. Pharmacist-Led Interventions for Inpatient HIV-Related Medication Errors
title_full_unstemmed 597. Pharmacist-Led Interventions for Inpatient HIV-Related Medication Errors
title_short 597. Pharmacist-Led Interventions for Inpatient HIV-Related Medication Errors
title_sort 597. pharmacist-led interventions for inpatient hiv-related medication errors
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254135/
http://dx.doi.org/10.1093/ofid/ofy210.604
work_keys_str_mv AT winglermaryjoyceb 597pharmacistledinterventionsforinpatienthivrelatedmedicationerrors
AT stoverkaylar 597pharmacistledinterventionsforinpatienthivrelatedmedicationerrors
AT barberkatiee 597pharmacistledinterventionsforinpatienthivrelatedmedicationerrors
AT wagnerjamiel 597pharmacistledinterventionsforinpatienthivrelatedmedicationerrors